Nifty

:

9580.30

Sensex

:

32424.10

90.20 (0.95%)
223.51 (0.69%)

Login

Nifty
Sensex

:
:

9580.30
32424.10

90.20 (0.95%)
223.51 (0.69%)

Abbott India Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

88/99

BSE: 500488 | NSE: ABBOTINDIA

Watchlist

NSE BSE

16723.40

29-May-2020

Open
High
Low
Previous Close

16700.00
16900.00
16594.05
16594.20

Volume
Traded Value (lacs)
52 Week High
52 Week Low

14746
2468.18
18679.75
7700.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

35,545.94
59.73
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

33,861.66
0.39%
15.33

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
9.95
8.22

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
14.18
8.88

PAT CAGR (%)

10 Years
5 Years
3 Years

-
14.49
17.63

P:E (Median)

8 Years
5 Years
3 Years

35.87
37.93
37.69

P:BV (Average)

8 Years
5 Years
3 Years

14.81
14.81
14.81

EV:EBITDA (Average)

8 Years
5 Years
3 Years

20.06
23.33
23.91

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 19 Dec 18 Var% Sep 19 Sep 18 Var% Jun 19 Jun 18 Var% Mar 19 Mar 18 Var%
Net Sales 1,078.25 947.65 13.78% 1,054.80 979.72 7.66% 998.89 844.92 18.22% 906.31 788.36 14.96%
Expenses 838.55 801.16 4.67% 850.67 785.71 8.27% 824.71 733.57 12.42% 753.41 681.74 10.51%
EBITDA 239.70 146.49 63.63% 204.13 194.01 5.22% 174.18 111.35 56.43% 152.90 106.62 43.41%
EBIDTM 22.23% 15.46% 19.35% 19.80% 17.44% 13.18% 16.87% 13.52%
Other Income 27.76 37.63 -26.23% 28.90 24.53 17.81% 29.60 21.76 36.03% 29.36 58.60 -49.90%
Interest 1.86 0.43 332.56% 1.82 0.52 250.00% 2.03 0.56 262.50% 0.75 2.21 -66.06%
Depreciation 15.05 3.96 280.05% 14.95 4.06 268.23% 14.80 3.99 270.93% 4.91 3.96 23.99%
PBT 250.55 179.73 39.40% 216.26 213.96 1.07% 186.95 128.56 45.42% 176.60 159.05 11.03%
Tax 63.86 62.68 1.88% 37.93 76.28 -50.28% 70.01 46.16 51.67% 63.41 58.97 7.53%
PAT 186.69 117.05 59.50% 178.33 137.68 29.52% 116.94 82.40 41.92% 113.19 100.08 13.10%
PATM 17.31% 12.35% 16.91% 14.05% 11.71% 9.75% 12.49% 12.69%
EPS 88.06 55.21 59.50% 84.12 64.94 29.53% 55.16 38.87 41.91% 53.39 47.21 13.09%

Description Dec 19 Dec 18 Var% Sep 19 Sep 18 Var% Jun 19 Jun 18 Var% Mar 19 Mar 18 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Dec 12 Dec 11 Dec 10 Nov 09
Net Sales 4,038.25 3,678.60 3,298.50 2,902.56 2,614.50 2,289.33 2,275.90 1,652.69 1,490.21 1,036.87 794.56 Net Sales Growth 13.41% 11.52% 13.64% 11.02% 14.20% 0.59% 37.71% 10.90% 43.72% 30.50% Cost Of Goods Sold 2,264.26 2,088.60 1,900.43 1,714.96 1,494.45 1,314.45 1,299.16 974.96 862.72 631.48 490.63 Gross Profit 1,773.99 1,590.01 1,398.07 1,187.60 1,120.05 974.87 976.75 677.72 627.49 405.39 303.93 GP Margin 43.93% 43.22% 42.39% 40.92% 42.84% 42.58% 42.92% 41.01% 42.11% 39.10% 38.25% Total Expenditure 3,267.34 3,074.56 2,775.10 2,507.75 2,250.77 1,978.01 2,008.62 1,451.27 1,314.83 967.43 697.24 Power & Fuel Cost - 12.61 10.26 7.74 6.98 5.96 9.08 9.06 8.37 6.97 5.10 % Of Sales - 0.34% 0.31% 0.27% 0.27% 0.26% 0.40% 0.55% 0.56% 0.67% 0.64% Employee Cost - 435.58 393.69 345.27 341.09 305.40 299.74 206.20 167.35 108.13 59.69 % Of Sales - 11.84% 11.94% 11.90% 13.05% 13.34% 13.17% 12.48% 11.23% 10.43% 7.51% Manufacturing Exp. - 14.42 11.52 13.14 11.94 11.59 18.29 6.19 4.30 25.36 20.81 % Of Sales - 0.39% 0.35% 0.45% 0.46% 0.51% 0.80% 0.37% 0.29% 2.45% 2.62% General & Admin Exp. - 267.14 239.06 205.33 191.08 152.91 192.05 113.38 111.64 48.33 28.88 % Of Sales - 7.26% 7.25% 7.07% 7.31% 6.68% 8.44% 6.86% 7.49% 4.66% 3.63% Selling & Distn. Exp. - 191.15 156.94 148.33 152.27 135.60 130.83 98.13 116.14 114.92 72.74 % Of Sales - 5.20% 4.76% 5.11% 5.82% 5.92% 5.75% 5.94% 7.79% 11.08% 9.15% Miscellaneous Exp. - 65.05 63.19 72.98 52.96 52.10 59.47 43.34 44.30 32.23 72.74 % Of Sales - 1.77% 1.92% 2.51% 2.03% 2.28% 2.61% 2.62% 2.97% 3.11% 2.44% EBITDA 770.91 604.04 523.40 394.81 363.73 311.32 267.28 201.42 175.38 69.44 97.32 EBITDA Margin 19.09% 16.42% 15.87% 13.60% 13.91% 13.60% 11.74% 12.19% 11.77% 6.70% 12.25% Other Income 115.62 113.98 118.09 60.15 51.24 48.48 49.29 22.70 19.80 35.99 29.28 Interest 6.46 2.25 3.82 2.04 2.52 0.50 0.08 0.02 0.03 0.04 0.20 Depreciation 49.71 16.92 16.19 16.43 14.44 14.94 21.93 19.49 15.00 11.25 9.01 PBT 830.36 698.85 621.48 436.49 398.01 344.36 294.55 204.60 180.16 94.14 117.38 Tax 235.21 248.52 220.26 159.84 142.76 115.40 96.10 70.29 59.77 33.21 39.87 Tax Rate 28.33% 35.56% 35.44% 36.62% 35.87% 33.51% 32.63% 32.69% 33.18% 35.28% 33.97% PAT 595.15 450.33 401.22 276.65 255.25 228.96 198.45 144.70 120.39 60.94 77.51 PAT before Minority Interest 595.15 450.33 401.22 276.65 255.25 228.96 198.45 144.70 120.39 60.94 77.51 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 14.74% 12.24% 12.16% 9.53% 9.76% 10.00% 8.72% 8.76% 8.08% 5.88% 9.76% PAT Growth 36.12% 12.24% 45.03% 8.38% 11.48% 15.37% 37.15% 20.19% 97.55% -21.38% EPS 280.73 212.42 189.25 130.50 120.40 108.00 93.61 68.25 56.79 28.75 36.56

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Dec 12 Dec 11 Dec 10 Nov 09
Shareholder's Funds 2,008.59 1,692.76 1,386.94 1,195.60 937.53 787.85 646.86 544.14 305.38 271.56 Share Capital 21.25 21.25 21.25 21.25 21.25 21.25 21.25 21.25 13.68 13.68 Total Reserves 1,959.59 1,650.56 1,352.37 1,174.35 916.28 766.60 625.61 522.89 291.71 257.88 Non-Current Liabilities 62.36 40.75 34.84 29.25 432.46 442.99 30.68 230.24 0.19 2.20 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 75.43 55.35 47.22 38.64 438.98 444.27 29.43 236.44 0.00 0.00 Current Liabilities 856.89 668.08 631.64 382.27 834.22 652.31 229.55 238.52 556.48 475.96 Trade Payables 663.52 480.62 474.69 230.14 193.56 136.22 101.35 120.90 57.75 43.11 Other Current Liabilities 89.42 81.80 77.90 86.90 59.35 53.91 44.09 41.28 40.21 14.79 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 103.96 105.66 79.05 65.23 581.31 462.18 84.11 76.35 458.52 418.06 Total Liabilities 2,927.84 2,401.59 2,053.42 1,607.12 2,204.21 1,883.15 907.09 1,012.90 862.05 749.72 Net Block 104.96 81.38 109.60 108.46 96.04 98.25 108.67 79.66 49.71 48.79 Gross Block 164.52 124.25 139.69 122.83 215.65 209.23 203.65 191.81 118.21 107.10 Accumulated Depreciation 59.56 42.87 30.10 14.37 119.61 110.98 94.98 112.15 68.50 58.31 Non Current Assets 166.85 136.12 160.41 156.49 540.81 540.48 133.23 326.64 50.57 49.15 Capital Work in Progress 0.73 2.17 6.28 2.83 3.91 1.27 0.51 0.36 0.86 0.36 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 56.69 48.91 41.53 42.47 438.62 438.94 22.88 246.62 0.00 0.00 Other Non Current Assets 4.47 3.66 3.00 2.73 2.24 2.02 1.17 0.00 0.00 0.00 Current Assets 2,760.98 2,265.47 1,893.02 1,450.63 1,663.39 1,342.67 773.86 686.26 811.48 700.56 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 606.79 585.33 500.63 370.10 384.13 359.05 263.63 254.90 128.59 102.38 Sundry Debtors 276.11 263.44 176.22 145.02 129.15 109.18 141.03 132.61 65.28 44.40 Cash & Bank 1,684.28 1,031.35 1,090.92 839.42 643.89 462.84 323.34 258.95 188.51 175.61 Other Current Assets 193.80 95.80 19.01 16.57 506.22 411.61 45.85 39.80 429.10 378.18 Short Term Loans & Adv. 93.24 289.55 106.23 79.51 488.68 397.22 41.15 33.69 427.90 377.75 Net Current Assets 1,904.09 1,597.39 1,261.38 1,068.36 829.17 690.36 544.31 447.74 255.00 224.61 Total Assets 2,927.83 2,401.59 2,053.43 1,607.12 2,204.20 1,883.15 907.09 1,012.90 862.05 749.71

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Dec 12 Dec 11 Dec 10 Nov 09
Cash From Operating Activity 499.13 152.70 307.22 248.68 214.78 155.31 101.35 24.07 46.06 37.16 PBT 698.85 621.48 436.49 398.01 344.36 294.55 214.99 180.16 94.14 117.38 Adjustment -77.46 -76.92 -37.02 -23.98 -37.19 -1.08 -9.23 1.40 6.57 4.35 Changes in Working Capital 134.41 -186.96 66.52 21.85 23.48 -28.45 -39.78 -97.28 -5.61 -46.35 Cash after chg. in Working capital 755.80 357.61 466.00 395.87 330.65 265.03 165.98 84.28 95.10 75.38 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -256.67 -204.90 -158.78 -147.20 -115.87 -109.71 -64.63 -60.21 -49.04 -38.22 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -257.00 -214.84 -155.41 -77.19 -186.72 -143.90 -58.51 5.05 -15.75 -0.83 Net Fixed Assets -38.83 19.55 -20.31 93.90 -9.06 -6.34 -11.99 -73.10 -11.61 -6.04 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others -218.17 -234.39 -135.10 -171.09 -177.66 -137.56 -46.52 78.15 -4.14 5.21 Cash from Financing Activity -142.80 -102.43 -89.76 -80.29 -57.58 -42.35 -42.01 -42.02 -27.24 -23.36 Net Cash Inflow / Outflow 99.33 -164.56 62.05 91.19 -29.52 -30.94 0.83 -12.90 3.08 12.96 Opening Cash & Equivalents 37.68 202.24 140.19 49.00 78.52 109.46 108.63 70.38 69.21 56.26 Closing Cash & Equivalent 137.01 37.68 202.24 140.19 49.00 78.52 109.46 108.63 72.29 69.21

Financial Ratios

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Dec 12 Dec 11 Dec 10 Nov 09
Book Value (Rs.) 932.19 786.76 646.43 562.65 441.20 370.77 304.41 256.08 223.31 198.58 ROA 16.90% 18.01% 15.12% 13.39% 11.20% 14.22% 15.07% 12.84% 7.56% 13.64% ROE 24.66% 26.35% 21.54% 23.93% 26.54% 27.66% 24.30% 28.34% 21.12% 31.46% ROCE 37.88% 40.61% 33.96% 37.55% 39.98% 41.07% 36.11% 42.42% 32.65% 47.65% Fixed Asset Turnover 25.48 25.06 22.39 15.63 10.91 11.19 8.47 9.73 9.26 7.78 Receivable days 26.77 24.26 19.95 18.91 18.77 19.78 29.82 23.94 19.19 17.51 Inventory Days 59.14 59.93 54.07 52.03 58.54 49.21 56.51 46.40 40.41 44.36 Payable days 76.56 66.93 54.71 38.57 32.92 23.41 31.17 26.13 19.87 31.05 Cash Conversion Cycle 9.35 17.26 19.31 32.37 44.39 45.58 55.17 44.21 39.74 30.81 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 311.82 163.60 215.33 158.63 685.07 3532.82 8996.52 6006.28 2433.69 580.67

Top Investors:

l and t mutual fund trustee limited - l and t mid cap fund

pnb metlife india insurance company limited

bharti axa life insurance company limited

aegon religare life insurance company limited

Annual Reports:

News Update:

Abbott launches new inactivated quadrivalent vaccine in India
24th Feb 2020, 15:20 PM

It is the only 0.5 ml quadrivalent flu vaccine in India that has been approved for use in children below three years
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback